These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3262993)

  • 1. Bambuterol, a bronchodilator prodrug with sustained action, enhances delivery of active drug to the lung.
    Svensson LA
    Agents Actions Suppl; 1988; 23():271-6. PubMed ID: 3262993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of bambuterol.
    Sitar DS
    Clin Pharmacokinet; 1996 Oct; 31(4):246-56. PubMed ID: 8896942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bambuterol: clinical effects of different doses of a long-acting bronchodilator prodrug.
    Sandström T; Asander L; Clemmensen IH; Eklund G; Gnosspelius Y; Klarlund Pedersen B; Persson G; Ravn S; Rosenhall L; Weeke B
    Respiration; 1988; 53(1):31-6. PubMed ID: 3387689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bambuterol: uptake and metabolism in guinea pig isolated lungs.
    Ryrfeldt A; Nilsson E; Tunek A; Svensson LA
    Pharm Res; 1988 Mar; 5(3):151-5. PubMed ID: 3244626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of bambuterol: a beta-agonist prodrug with sustained lung affinity.
    Svensson LA
    Agents Actions Suppl; 1991; 34():71-8. PubMed ID: 1686529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group.
    Kuusela AL; Marenk M; Sandahl G; Sanderud J; Nikolajev K; Persson B
    Pediatr Pulmonol; 2000 Mar; 29(3):194-201. PubMed ID: 10686040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of bambuterol in healthy subjects.
    Nyberg L; Rosenborg J; Weibull E; Jönsson S; Kennedy BM; Nilsson M
    Br J Clin Pharmacol; 1998 May; 45(5):471-8. PubMed ID: 9643620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.
    Bang U; Nyberg L; Rosenborg J; Viby-Mogensen J
    Br J Clin Pharmacol; 1998 May; 45(5):479-84. PubMed ID: 9643621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of bambuterol, a long-acting bronchodilator pro-drug of terbutaline, in young and elderly patients with asthma.
    Sitar DS; Warren CP; Aoki FY
    Clin Pharmacol Ther; 1992 Sep; 52(3):297-306. PubMed ID: 1526088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration.
    D'Alonzo GE; Smolensky MH; Feldman S; Gnosspelius Y; Karlsson K
    Chest; 1995 Feb; 107(2):406-12. PubMed ID: 7842769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bambuterol: clinical effects of three doses of bambuterol once daily in asthmatic patients.
    Clemmensen IH; Pedersen BK; Ravn S; Laursen LC; Weeke B
    Allergy; 1988 Nov; 43(8):573-6. PubMed ID: 3061311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bambuterol: a new long acting bronchodilating prodrug.
    Vilsvik JS; Langaker O; Persson G; Ringdal N; Schaanning J; Kvelstad G; Svensson K; Holthe S; Soliman S
    Ann Allergy; 1991 Apr; 66(4):315-9. PubMed ID: 2014931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults.
    Rosenborg J; Larsson P; Nyberg L
    Br J Clin Pharmacol; 2000 Mar; 49(3):199-206. PubMed ID: 10718774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bambuterol: effects of a new anti-asthmatic drug.
    Pedersen BK; Laursen LC; Gnosspelius Y; Faurschou P; Weeke B
    Eur J Clin Pharmacol; 1985; 29(4):425-7. PubMed ID: 3912186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irrational combination of montelukast and bambuterol for management of childhood asthma.
    Kabra SK; Lodha R
    Indian Pediatr; 2006 Aug; 43(8):743-4. PubMed ID: 16951444
    [No Abstract]   [Full Text] [Related]  

  • 16. Bambuterol raises high-density lipoprotein levels in patients with hyperlipidaemia.
    Florén CH; Kjellström T; Bauer CA
    J Intern Med; 1997 Aug; 242(2):167-71. PubMed ID: 9279294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bambuterol: new preparation. Poorly demonstrated efficacy.
    Prescrire Int; 1999 Jun; 8(41):70-1. PubMed ID: 10558442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bambuterol: dose response study of a new terbutaline prodrug in asthma.
    Holstein-Rathlou NH; Laursen LC; Madsen F; Svendsen UG; Gnosspelius Y; Weeke B
    Eur J Clin Pharmacol; 1986; 30(1):7-11. PubMed ID: 3519240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treat patients who have nocturnal asthma with anti-inflammatory drugs first.
    Wempe JB; Oosterhoff Y; Koeter GH; Postma DS
    Chest; 1996 Apr; 109(4):1130. PubMed ID: 8635351
    [No Abstract]   [Full Text] [Related]  

  • 20. One month treatment with the once daily oral beta 2-agonist bambuterol in asthmatic patients.
    Persson G; Baas A; Knight A; Larsen B; Olsson H
    Eur Respir J; 1995 Jan; 8(1):34-9. PubMed ID: 7744191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.